Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis 

Slides:



Advertisements
Similar presentations
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Advertisements

Tuomo Puhakka, MDa, Mika J
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Evaluation and treatment of allergic fungal sinusitis. II
F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 
Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study  Eli O. Meltzer, MD, Paul.
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis  William R. Lumry, MD  Journal of.
The editors’ choice Journal of Allergy and Clinical Immunology
Eosinophil cationic protein and histamine after intestinal challenge in patients with cow's milk intolerance  Ulf Bengtsson, MD, PhDa, Tina W. Knutson,
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children  Mark Boguniewicz, MDa, Virginia C. Fiedler,
Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,
Allergen vaccination with a liposome-encapsulated extract of Dermatophagoides pteronyssinus : A randomized, double-blind, placebo-controlled trial in.
Evaluation and treatment of allergic fungal sinusitis. II
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis 
The effect of omalizumab on nasal allergic inflammation
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Bruce M. Prenner, MD, Bobby Q. Lanier, MD, David I
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of.
Badrul A. Chowdhury, MD, PhD 
Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen  Maria-Helena Terrien, MD, François Rahm, MD, Jean-Marc.
Chronic sinusitis in severe asthma is related to sputum eosinophilia
Pathophysiology of severe asthma
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis  Albert Jen, MD, Fuad Baroody, MD, Marcy de Tineo,
Edwin A. Bronsky, MD, Howard Druce, MD, Steven R. Findlay, MD, Frank C
Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W
Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol  Henry Milgrom, MDa, David P. Skoner,
Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic.
Effect of acetazolamide on cough induced by low-chloride-ion solutions in normal subjects: Comparison with furosemide  Antonio Foresi, MD, Giampaolo Cavigioli,
A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model  John M.
A review of the current guidelines for allergic rhinitis and asthma
Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: Effects of single allergen challenge  Adriaan.
Quality of life in adults and children with allergic rhinitis
Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization  Qutayba Hamid, MD, PhD, Editor  Journal.
Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years’ duration  Kawa.
Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray  Eli O. Meltzer,
Molecular virology and immunology of HIV infection
Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: Effect of topical corticosteroids  Keisuke.
Exercise-induced bronchoconstriction in children: Montelukast attenuates the immediate-phase and late-phase responses  Raul E. Melo, MD, Dirceu Solé,
F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 
Model for outcomes assessment of antihistamine use for seasonal allergic rhinitis  Robert P. Harvey, MD, Carolyn Comer, MD, Barbara Sanders, MD, Ross Westley,
Thomas B. Casale, MDa, I. Leonard Bernstein, MDb, William W
News & Notes Journal of Allergy and Clinical Immunology
Corticosteroid-induced apoptosis in mouse airway epithelium: Effect in normal airways and after allergen-induced airway inflammation  Delbert R. Dorscheid,
Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic.
Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation  Alex.
A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein.
Loratadine reduces allergen-induced mucosal output of α2-macroglobulin and tryptase in allergic rhinitis  Lennart Greiff, MD, PhDa, Carl G.A. Persson,
Chemokines in seasonal allergic rhinitis
Seasonal rhinitis and azelastine: Long- or short-term treatment
Seasonal intestinal inflammation in patients with birch pollen allergy
Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis  Carmen Rondón, MD, PhD, Javier.
Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis  Toyoyuki Hanazawa, MD, PhD, Julio.
Corticosteroids in the treatment of pediatric allergic rhinitis
Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis  Ellinor Ädelroth, MD, PhDa, Sabina Rak, MD, PhDb,
Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways  Gert-Jan Braunstahl, MDa, b, Shelley.
Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: Effect of topical corticosteroids  Pota Christodoulopoulos, BSca,
Jonathan M. Corne, MRCPa, Catherine H. Linaker, BNa, Peter H
Tuomo Puhakka, MDa, Mika J
Larry C. Borish, MDa, Harold S
Airway remodeling-associated mediators in moderate to severe asthma: Effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression 
Successful treatment of eosinophilic gastroenteritis with suplatast tosilate  Toshihiro Shirai, MD, Dai Hashimoto, MD, Kenichiro Suzuki, MD, Satoru Osawa,
The correlation between allergic rhinitis and sleep disturbance
Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial  Eli O. Meltzer, MDa,
The effects of an H3 receptor antagonist (PF ) with fexofenadine on reducing allergic rhinitis symptoms  Jeffrey R. Stokes, MD, Francisco A. Romero,
Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal.
Myosin light chain kinase mediates eosinophil chemotaxis in a mitogen-activated protein kinase–dependent manner  Tetsuya Adachi, MDa, Susan Stafford,
Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal.
Presentation transcript:

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis  Teet Pullerits, MD, PhDa, Lea Praks, MD, PhDb, Vahur Ristioja, MDc, Jan Lötvall, MD, PhDa  Journal of Allergy and Clinical Immunology  Volume 109, Issue 6, Pages 949-955 (June 2002) DOI: 10.1067/mai.2002.124467 Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 1 Study design and grass pollen counts in the study area. Journal of Allergy and Clinical Immunology 2002 109, 949-955DOI: (10.1067/mai.2002.124467) Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 2 Mean daytime (left panel) and nighttime (right panel) symptom scores in patients with grass pollen-induced allergic rhinitis treated for 50 days with FPANS (200 μg/d), montelukast (ML ; 10 mg/d), a combination of montelukast and loratadine (ML+LT ; 10 mg/d), or placebo. Journal of Allergy and Clinical Immunology 2002 109, 949-955DOI: (10.1067/mai.2002.124467) Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 3 Mean symptom score for nasal blockage, sneezing, rhinorrhea, and nasal itching in patients with allergic rhinitis treated with FPANS, montelukast (ML) , a combination of montelukast and loratadine (ML+LT) , or placebo (*P < .05). Journal of Allergy and Clinical Immunology 2002 109, 949-955DOI: (10.1067/mai.2002.124467) Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 4 The grass pollen-induced change (means ± SEMs) in the number of EG2+ epithelial and subepithelial eosinophils per square millimeter (EOS/sqmm) in nasal biopsy specimens of patients with allergic rhinitis treated with FPANS, montelukast (ML) , a combination of montelukast and loratadine (ML+LT) , or placebo (*P < .05). Journal of Allergy and Clinical Immunology 2002 109, 949-955DOI: (10.1067/mai.2002.124467) Copyright © 2002 Mosby, Inc. Terms and Conditions